Rankings
▼
Calendar
LXRX Q4 2018 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
LXRX
Lexicon Pharmaceuticals, Inc.
$693M
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$17M
-48.3% YoY
Gross Profit
$17M
96.7% margin
Operating Income
-$12M
-72.4% margin
Net Income
-$17M
-98.3% margin
EPS (Diluted)
$-0.16
QoQ Revenue Growth
+149.0%
Cash Flow
Operating Cash Flow
-$27M
Free Cash Flow
-$27M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$284M
Total Liabilities
$311M
Stockholders' Equity
-$26M
Cash & Equivalents
$160M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$17M
$33M
-48.3%
Gross Profit
$17M
$33M
-49.2%
Operating Income
-$12M
-$31M
+59.8%
Net Income
-$17M
-$28M
+40.9%
← FY 2018
All Quarters
Q1 2019 →